MarketCap
Xenetic Biosciences XBIO
$ 1.87
-1.06%
Facebook
X
Telegram
Xenetic Biosciences EV - Enterprise Value | XBIO
Annual EV - Enterprise Value Xenetic Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.54 M | -1.31 M | -2.14 M | -11.5 M | -7.06 M | 4.36 M | -1.73 M | 22.5 M | 18.6 M | 35.7 M | 13.1 M | 5.82 M | -4.17 M | -10.7 M | -16.9 M |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.7 M | -16.9 M | 2.8 M |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Amicus Therapeutics
FOLD
|
4.89 B | - | - | $ 4.47 B |  USA |
 |
Frequency Therapeutics
FREQ
|
40.2 M | - | - | $ 528 M | USA |
|
Galecto
GLTO
|
-237 M | - | - | $ 762 M |  Danmark |
 |
GlycoMimetics
GLYC
|
-176 M | - | 9357.83 % | $ 1.01 B | USA |
 |
Graybug Vision
GRAY
|
8.71 M | - | -11.23 % | $ 9.65 M | USA |
|
Galera Therapeutics
GRTX
|
-5.73 M | - | -32.59 % | $ 7.61 M | USA |
 |
Happiness Biotech Group Limited
HAPP
|
-6.44 M | - | 1.35 % | $ 17.8 M |  China |
 |
Novavax
NVAX
|
2.91 B | $ 10.83 | 10.69 % | $ 1.75 B | USA |
 |
Hepion Pharmaceuticals
HEPA
|
-1.05 M | - | -18.79 % | $ 39.3 K | USA |
 |
Hoth Therapeutics
HOTH
|
6.39 M | - | - | $ 18.8 M | USA |
 |
IMARA
IMRA
|
-82.3 M | - | 15.96 % | $ 663 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
944 M | - | - | $ 1.45 B |  Britain |
 |
KemPharm
KMPH
|
67.7 M | - | -0.34 % | $ 200 M | USA |
 |
Kezar Life Sciences
KZR
|
-19.9 M | - | - | $ 53.3 M | USA |
 |
Lixte Biotechnology Holdings
LIXT
|
23.7 M | - | - | $ 63.4 M | USA |
 |
Magenta Therapeutics
MGTA
|
-13.6 M | - | -7.74 % | $ 41.6 M | USA |
 |
NovaBay Pharmaceuticals
NBY
|
640 M | - | - | $ 11.3 M | USA |
 |
NeuroBo Pharmaceuticals
NRBO
|
-4.49 M | - | 0.43 % | $ 12 M | USA |
 |
OncoCyte Corporation
OCX
|
45.6 M | - | 17.22 % | $ 355 K | USA |
 |
Onconova Therapeutics
ONTX
|
7.43 M | - | -0.47 % | $ 21 M | USA |
 |
Opthea Limited
OPT
|
209 M | - | - | $ 1.2 B |  Australia |
 |
Verastem
VSTM
|
388 M | $ 8.55 | -8.85 % | $ 593 M | USA |
|
BiomX
PHGE
|
4.2 M | $ 1.85 | 14.2 % | $ 3.02 M |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
-26.4 M | - | -15.58 % | $ 1.22 B |  Germany |
 |
Plus Therapeutics
PSTV
|
30.6 M | - | - | $ 301 M | USA |
 |
Pluristem Therapeutics
PSTI
|
-3.53 M | - | -1.9 % | $ 33.3 M | Israel |
 |
Qualigen Therapeutics
QLGN
|
-19.3 M | - | 5.59 % | $ 1.16 M | USA |
|
Qilian International Holding Group Limited
QLI
|
32.1 M | - | -6.08 % | $ 184 M | China |
 |
Cassava Sciences
SAVA
|
51.3 M | - | - | $ 110 M | USA |
 |
Selecta Biosciences
SELB
|
298 M | - | -8.69 % | $ 126 M | USA |
 |
Sangamo Therapeutics
SGMO
|
140 M | - | - | $ 50.4 M | USA |
 |
Salarius Pharmaceuticals
SLRX
|
-5.54 M | - | - | $ 2.64 M | USA |
 |
Sensei Biotherapeutics
SNSE
|
27.3 M | - | - | $ 17.5 M | USA |
 |
Sonnet BioTherapeutics Holdings
SONN
|
-1.02 M | - | - | $ 826 K | USA |
 |
Synthetic Biologics
SYN
|
9.8 M | - | 1.32 % | $ 16.2 M | USA |
 |
Synlogic
SYBX
|
-14.7 M | - | - | $ 7.07 M | USA |
 |
Virios Therapeutics, LLC
VIRI
|
8.75 M | - | 2710.01 % | $ 72.9 M | USA |
 |
Vallon Pharmaceuticals
VLON
|
-5.57 M | - | -6.47 % | $ 5.76 M | USA |
 |
Vaxart
VXRT
|
187 M | - | -25.06 % | $ 46.3 M | USA |
 |
XOMA Corporation
XOMA
|
416 M | - | - | $ 485 M | USA |
 |
Repare Therapeutics
RPTX
|
-9.3 M | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
66.6 M | - | 7.29 % | $ 127 M | USA |
|
Windtree Therapeutics
WINT
|
81.3 M | - | - | $ 26.8 M | USA |
 |
Trean Insurance Group
TIG
|
1.47 B | - | - | $ 316 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
-3.96 M | - | 57.95 % | $ 12.8 M | USA |
 |
MEI Pharma
MEIP
|
-4.64 M | - | 10.43 % | $ 20.5 M | USA |
 |
Palatin Technologies
PTN
|
-5.65 M | - | - | $ 13 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - |  Russia |
 |
Lyra Therapeutics
LYRA
|
30.9 M | - | - | $ 24.9 M | USA |